Bladder diary
Diagnostic Test3-day bladder diary
NCT Number: NCT03806855
Overactive bladder syndrome (OAB) has a great negative impact on health-related quality of life. In literatures, few studies reported the comparisons of health related quality of life between OAB-wet and OAB-dry female patients. Thus, our aim is to compare the clinical variables and health-related quality of life between OAB-wet and OAB-dry women.
Looking for future studies?
Notify Me20 year and older
Female
Observational
Between July 2009 and January 2018, all women with OAB visiting a medical center for evaluation were reviewed. The classification of OAB-wet or OAB-dry is based on the record of the three-day bladder diary of each patient. The diagnosis of OAB in each patient was based on the presence of at least one episode of urgency in her three-day bladder diary and with the absence of stress urinary incontinence. The presence of at least one episode of urgency associated incontinence was defined to be OAB-wet, otherwise, OAB-dry. Besides, only female OAB patients with available King's Health Questionnaire (KHQ) data were reviewed in this study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3-day bladder diary
Time frame: Between July 2009 and January 2018
Use questionnaire to evaluate the difference in QoF of OAB-wet and OAB-dry women
National Taiwan University Hospital
Other
Comparisons of Health-Related Quality of Life Between Overactive Bladder-wet and -Dry Women Based on Bladder Diary
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06508944
Bladder, Overactive, Female Genitourinary Disease
Ratchathewi, Bangkok, Thailand
View Trial DetailsNCT04068025
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01486706
Detrusor Uninhibited Activity, Female Urogenital Diseases
Quezon City, National Capital Region, Philippines
View Trial DetailsNCT00224146
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Mobile, Alabama, United States
View Trial Details